Digital Twins in Pharmacology: Shaping the Future of Personalized Drug Therapy.

The field of pharmacy is undergoing a remarkable transformation with the integration of advanced
digital technologies. One of the most promising innovations is the concept of digital twins virtual
models that replicate the structure and function of biological systems. In pharmacology, digital
twins can simulate an individual patient’s physiology, disease progression, and drug response,
offering a new dimension to personalized medicine. Traditional pharmacotherapy often follows a
“one-size-fits-all” approach, which may lead to variability in drug efficacy and an increased risk of
adverse effects. By contrast, digital twins supported by artificial intelligence (AI), big data analytics,
and pharmacogenomics can predict patient-specific outcomes, optimize dosage regimens, and
minimize trial-and-error prescribing. This not only enhances therapeutic precision but also improves
patient safety and overall healthcare quality. The application of digital twins in pharmacology
extends beyond individualized therapy. They also play a significant role in drug discovery, clinical
trials, and pharmacovigilance. By creating virtual simulations, researchers can reduce dependence
on animal testing, lower research costs, and accelerate the development of innovative therapies. For
practicing pharmacists, digital twins can act as powerful decision-support tools, enabling evidence
based and patient-centered care. As pharmacy education embraces technological advancements,
future pharmacists must be equipped with the knowledge and skills to harness these tools. Digital
twins exemplify the intersection of pharmacology and technology, symbolizing a shift towards
smarter, safer, and more personalized drug therapy. This poster emphasizes their transformative
role in empowering the next generation of pharmacists in the era of precision medicine.